Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 113

1.

Extreme under-reporting of body weight by young adults with obesity: relation to social desirability.

King BM, Cespedes VM, Burden GK, Brady SK, Clement LR, Abbott EM, Baughman KS, Joyner SE, Clark MM, Pury CLS.

Obes Sci Pract. 2018 Feb 2;4(2):129-133. doi: 10.1002/osp4.153. eCollection 2018 Apr.

2.

Does the Centers for Disease Control and Prevention's Youth Risk Behavior Survey Underreport Risky Sexual Behavior?

King BM, Marino LE, Barry KR.

Sex Transm Dis. 2018 Mar;45(3):e10-e11. doi: 10.1097/OLQ.0000000000000704. No abstract available.

PMID:
28876287
3.

A novel conditional Sgsh knockout mouse model recapitulates phenotypic and neuropathic deficits of Sanfilippo syndrome.

Lau AA, King BM, Thorsen CL, Hassiotis S, Beard H, Trim PJ, Whyte LS, Tamang SJ, Duplock SK, Snel MF, Hopwood JJ, Hemsley KM.

J Inherit Metab Dis. 2017 Sep;40(5):715-724. doi: 10.1007/s10545-017-0044-4. Epub 2017 Apr 27.

PMID:
28451919
4.

Town & Gown.

King BM, Gordon SC, Barry CD, Goodman R, Jannone LT, Foley M, Resha C, Hendershot C.

NASN Sch Nurse. 2017 Jan;32(1):14-18. doi: 10.1177/1942602X16681819.

PMID:
28033073
5.

Efficient Computation of Small-Molecule Configurational Binding Entropy and Free Energy Changes by Ensemble Enumeration.

Silver NW, King BM, Nalam MN, Cao H, Ali A, Kiran Kumar Reddy GS, Rana TM, Schiffer CA, Tidor B.

J Chem Theory Comput. 2013 Nov 12;9(11):5098-5115. Epub 2013 Aug 7.

6.

Crystal structure of an HSA/FcRn complex reveals recycling by competitive mimicry of HSA ligands at a pH-dependent hydrophobic interface.

Schmidt MM, Townson SA, Andreucci AJ, King BM, Schirmer EB, Murillo AJ, Dombrowski C, Tisdale AW, Lowden PA, Masci AL, Kovalchin JT, Erbe DV, Wittrup KD, Furfine ES, Barnes TM.

Structure. 2013 Nov 5;21(11):1966-78. doi: 10.1016/j.str.2013.08.022. Epub 2013 Oct 10.

7.

Design of a superior cytokine antagonist for topical ophthalmic use.

Hou J, Townson SA, Kovalchin JT, Masci A, Kiner O, Shu Y, King BM, Schirmer E, Golden K, Thomas C, Garcia KC, Zarbis-Papastoitsis G, Furfine ES, Barnes TM.

Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3913-8. doi: 10.1073/pnas.1217996110. Epub 2013 Feb 19.

8.

Neonatal Bone Marrow Transplantation in MPS IIIA Mice.

Lau AA, Shamsani NJ, Winner LK, Hassiotis S, King BM, Hopwood JJ, Hemsley KM.

JIMD Rep. 2013;8:121-32. doi: 10.1007/8904_2012_169. Epub 2012 Aug 10.

9.

The modern obesity epidemic, ancestral hunter-gatherers, and the sensory/reward control of food intake.

King BM.

Am Psychol. 2013 Feb-Mar;68(2):88-96. doi: 10.1037/a0030684. Epub 2012 Dec 17. Review.

PMID:
23244211
10.

Efficient calculation of molecular configurational entropies using an information theoretic approximation.

King BM, Silver NW, Tidor B.

J Phys Chem B. 2012 Mar 8;116(9):2891-904. doi: 10.1021/jp2068123. Epub 2012 Feb 22.

11.

A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes.

Doherty KM, Nakka P, King BM, Rhee SY, Holmes SP, Shafer RW, Radhakrishnan ML.

BMC Bioinformatics. 2011 Dec 15;12:477. doi: 10.1186/1471-2105-12-477.

12.

Pharmacokinetic characterization of a natural product-inspired novel MEK1 inhibitor E6201 in preclinical species.

Kumar V, Schuck EL, Pelletier RD, Farah N, Condon KB, Ye M, Rowbottom C, King BM, Zhang ZY, Saxton PL, Wong YN.

Cancer Chemother Pharmacol. 2012 Jan;69(1):229-37. doi: 10.1007/s00280-011-1687-8. Epub 2011 Jun 23.

PMID:
21698359
13.

Treatment of canine fucosidosis by intracisternal enzyme infusion.

Kondagari GS, King BM, Thomson PC, Williamson P, Clements PR, Fuller M, Hemsley KM, Hopwood JJ, Taylor RM.

Exp Neurol. 2011 Aug;230(2):218-26. doi: 10.1016/j.expneurol.2011.04.019. Epub 2011 May 6.

PMID:
21575633
14.

Olfactory bulbectomy impairs the feeding response to 2-deoxy-D-glucose in rats.

King BM, Primeaux SD, Zadeh ML, de Gruiter JE, Plant JD, Ferguson AV, Bray GA.

Brain Res. 2011 Jan 7;1367:207-12. doi: 10.1016/j.brainres.2010.10.040. Epub 2010 Oct 20.

15.

Point: a call for proper usage of "gender" and "sex" in biomedical publications.

King BM.

Am J Physiol Regul Integr Comp Physiol. 2010 Jun;298(6):R1700-1. doi: 10.1152/ajpregu.00694.2009. Epub 2010 Mar 31. No abstract available.

16.

A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: the VULCAN trial.

Michaels JA, Campbell WB, King BM, Macintyre J, Palfreyman SJ, Shackley P, Stevenson MD.

Health Technol Assess. 2009 Nov;13(56):1-114, iii. doi: 10.3310/hta13560.

17.

Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity.

Cosgrove BD, King BM, Hasan MA, Alexopoulos LG, Farazi PA, Hendriks BS, Griffith LG, Sorger PK, Tidor B, Xu JJ, Lauffenburger DA.

Toxicol Appl Pharmacol. 2009 Jun 15;237(3):317-30. doi: 10.1016/j.taap.2009.04.002. Epub 2009 Apr 9.

18.

MIST: Maximum Information Spanning Trees for dimension reduction of biological data sets.

King BM, Tidor B.

Bioinformatics. 2009 May 1;25(9):1165-72. doi: 10.1093/bioinformatics/btp109. Epub 2009 Mar 4.

19.

Effect of high dose, repeated intra-cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice.

Mader KM, Beard H, King BM, Hopwood JJ.

Genes Brain Behav. 2008 Oct;7(7):740-53. doi: 10.1111/j.1601-183X.2008.00413.x.

20.

Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4.

Zhang ZY, King BM, Pelletier RD, Wong YN.

Cancer Chemother Pharmacol. 2008 Sep;62(4):707-16. doi: 10.1007/s00280-008-0755-1. Epub 2008 Apr 23.

PMID:
18431572

Supplemental Content

Support Center